Cargando…

Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia‐like phenotype, and no chromosome fragility

BACKGROUND: Biallelic BRCA1 mutations are regarded either embryonically lethal or to cause Fanconi anemia (FA), a genomic instability syndrome characterized by bone marrow failure, developmental abnormalities, and cancer predisposition. We report biallelic BRCA1 mutations c.181T > G (p.Cys61Gly)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keupp, Katharina, Hampp, Stephanie, Hübbel, Annette, Maringa, Monika, Kostezka, Sarah, Rhiem, Kerstin, Waha, Anke, Wappenschmidt, Barbara, Pujol, Roser, Surrallés, Jordi, Schmutzler, Rita K., Wiesmüller, Lisa, Hahnen, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732317/ https://www.ncbi.nlm.nih.gov/pubmed/31347298 http://dx.doi.org/10.1002/mgg3.863

Ejemplares similares

Non-small cell neuroendocrine carcinoma of the ovary in a BRCA2-germline mutation carrier: A case report and brief review of the literature
por: Herold, Natalie, et al.
Publicado: (2018)

Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history
por: Engel, Christoph, et al.
Publicado: (2018)

Bcr/Abl Interferes with the Fanconi Anemia/BRCA Pathway: Implications in the Chromosomal Instability of Chronic Myeloid Leukemia Cells
por: Valeri, Antonio, et al.
Publicado: (2010)

Analysis of 30 Putative BRCA1 Splicing Mutations in Hereditary Breast and Ovarian Cancer Families Identifies Exonic Splice Site Mutations That Escape In Silico Prediction
por: Wappenschmidt, Barbara, et al.
Publicado: (2012)

Biallelic BRCA Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline BRCA1/2 Carriers
por: Wineland, Dylane, et al.
Publicado: (2023)

Strong evidence that the common variant S384F in BRCA2 has no pathogenic relevance in hereditary breast cancer
por: Wappenschmidt, B, et al.
Publicado: (2005)

Haplotype analysis in German families with recurrent BRCA1 and BRCA2 mutations
por: Wappenschmidt, B, et al.
Publicado: (2001)

Satisfaction and Quality of Life of Healthy and Unilateral Diseased BRCA1/2 Pathogenic Variant Carriers after Risk-Reducing Mastectomy and Reconstruction Using the BREAST-Q Questionnaire
por: Herold, Natalie, et al.
Publicado: (2022)

Disseminated Medulloblastoma in a Child with Germline BRCA2 6174delT Mutation and without Fanconi Anemia
por: Xu, Jingying, et al.
Publicado: (2015)

Prevalence of Pathogenic Germline Variants in Women with Non-Familial Unilateral Triple-Negative Breast Cancer
por: Rhiem, Kerstin, et al.
Publicado: (2023)

TALEN mediated gene editing in a mouse model of Fanconi anemia
por: Pino-Barrio, Maria José, et al.
Publicado: (2020)

Biallelic Germline Transcription at the κ Immunoglobulin Locus
por: Singh, Nandita, et al.
Publicado: (2003)

Large Deletions in the BRCA1 Gene Are Not Common in a Set of Familial German Breast Cancer Patients
por: Maringa, M., et al.
Publicado: (1999)

Fanconi Anaemia, Childhood Cancer and the BRCA Genes
por: Woodward, Emma R., et al.
Publicado: (2021)

Incidence and Prognostic Impact of Deleterious Germline Mutations in Primary Advanced Ovarian Carcinoma Patients
por: Imterat, Majdi, et al.
Publicado: (2023)

SNV/indel hypermutator phenotype in biallelic RAD51C variant - Fanconi anemia
por: Zemet, Roni, et al.
Publicado: (2023)

Contribution of BRCA1 and BRCA2 Germline Mutations to Early Algerian Breast Cancer
por: Henouda, Sarra, et al.
Publicado: (2016)

Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia
por: Casado, José A., et al.
Publicado: (2022)

Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer
por: Muranen, Taru A., et al.
Publicado: (2020)

RAD51C deletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families
por: Schnurbein, Gioia, et al.
Publicado: (2013)

Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer
por: Herold, Natalie, et al.
Publicado: (2023)

Gene panel testing of 5589 BRCA1/2‐negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer
por: Hauke, Jan, et al.
Publicado: (2018)

Performance of In Silico Prediction Tools for the Detection of Germline Copy Number Variations in Cancer Predisposition Genes in 4208 Female Index Patients with Familial Breast and Ovarian Cancer
por: Lepkes, Louisa, et al.
Publicado: (2021)

Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia
por: Lasaga, Miren, et al.
Publicado: (2023)

Arrhythmogenic right ventricular cardiomyopathy in patients with biallelic JUP-associated skin fragility
por: Vahidnezhad, Hassan, et al.
Publicado: (2020)

Biallelic germline nonsense variant of MLH3 underlies polyposis predisposition
por: Olkinuora, Alisa, et al.
Publicado: (2018)

Prevalence of Cancer Predisposition Germline Variants in Male Breast Cancer Patients: Results of the German Consortium for Hereditary Breast and Ovarian Cancer
por: Rolfes, Muriel, et al.
Publicado: (2022)

High content drug screening for Fanconi anemia therapeutics
por: Montanuy, Helena, et al.
Publicado: (2020)

Decision Aids for Preventive Treatment Alternatives for BRCA1/2 Mutation Carriers: a Systematic Review
por: Krassuski, Lisa Marlene, et al.
Publicado: (2021)

Long-term survival of a BRCA2 mutation carrier following second ovarian cancer relapse using PARPi therapy: A case report
por: Bredow, Kathrin, et al.
Publicado: (2022)

Effectiveness of evidence-based decision aids for women with pathogenic BRCA1 or BRCA2 variants in the german health care context: results from a randomized controlled trial
por: Kautz-Freimuth, Sibylle, et al.
Publicado: (2023)

Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics
por: Ernst, Corinna, et al.
Publicado: (2018)

Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemia
por: Pouliot, Gayle P., et al.
Publicado: (2019)

Clinical consequences of BRCA2 hypomorphism
por: Castells-Roca, Laia, et al.
Publicado: (2021)

Psychological factors and the uptake of preventative measures in BRCA1/2 pathogenic variant carriers: results of a prospective cohort study
por: Dick, Julia, et al.
Publicado: (2022)

The germline mutational landscape of BRCA1 and BRCA2 in Brazil
por: Palmero, Edenir Inêz, et al.
Publicado: (2018)

Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making
por: Kautz-Freimuth, Sibylle, et al.
Publicado: (2021)

BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer
por: Nakashima, Shinsuke, et al.
Publicado: (2015)

Cooperation of the NEIL3 and Fanconi anemia/BRCA pathways in interstrand crosslink repair
por: Li, Niu, et al.
Publicado: (2020)

Fanconi Anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML
por: Przychodzen, Bartlomiej, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_td1ssv6o0lc8b838i5ftj6u1a3